Insider Shareholders with Direct Ownership of Arrowhead Pharmaceuticals, Inc. (ARWR)
This section provides a comprehensive overview of the insiders with direct ownership of Arrowhead Pharmaceuticals, Inc. (ARWR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ARROWHEAD PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Christopher Richard Anzalone
Chief Executive Officer |
2,450,143 | 1,337,201 | 3,773,802 $75.1 Million | 38 |
Feb 07, 2025
Added 0.25%
|
|
Patrick O'Brien
COO and General Counsel |
520,000 | 251,174 | 527,201 $10.5 Million | 19 |
Jan 07, 2025
Reduced 1.49%
|
|
Kenneth Allen Myszkowski
Chief Financial Officer |
427,671 | 303,230 | 455,433 $9.06 Million | 19 |
Jan 07, 2025
Reduced 2.15%
|
|
James C Hamilton
Chief Discovery/Trans Medicine |
340,000 | 186,628 | 272,122 $5.42 Million | 18 |
Jan 06, 2025
Reduced 3.88%
|
|
Martin Javier San
Chief Medical Officer |
135,000 | 86,503 | 198,497 $3.95 Million | 7 |
Jan 05, 2024
Reduced 2.17%
|
|
Michael S Perry
Director |
54,987 | 8,500 | 131,490 $2.62 Million | 7 |
Dec 18, 2024
Added 11.29%
|
|
Tracie Oliver
Chief Commercial Officer |
75,500 | 18,393 | 127,107 $2.53 Million | 5 |
Jul 02, 2024
Reduced 6.88%
|
|
Douglas B Given
Director |
39,409 | 70,058 | 124,167 $2.47 Million | 17 |
Dec 17, 2024
Reduced 0.44%
|
|
James Hassard
Chief Commercial Officer |
0 | 19,250 | 105,750 $2.1 Million | 2 |
Jun 22, 2021
Reduced 3.31%
|
|
Mauro Ferrari
Director |
54,987 | 16,547 | 77,514 $1.54 Million | 8 |
Dec 18, 2024
Added 17.75%
|
|
William D. Waddill
Director |
54,987 | 25,879 | 57,111 $1.14 Million | 12 |
Dec 18, 2024
Added 22.66%
|
|
Lu Hongbo
Director |
19,733 | 0 | 47,163 $938,543 | 4 |
Dec 18, 2024
Added 26.19%
|
|
Douglas S Ingram
Director |
38,396 | 0 | 38,396 $764,080 | 1 |
Feb 06, 2025
Added 50.0%
|
|
Victoria Vakiener
Director |
39,587 | 18,827 | 37,944 $755,085 | 8 |
Dec 18, 2024
Added 30.6%
|
|
Adeoye Y Olukotun
Director |
54,987 | 24,209 | 35,781 $712,041 | 10 |
Jan 23, 2025
Reduced 2.61%
|
|
Marianne De Backer
Director |
24,267 | 9,500 | 31,267 $622,213 | 6 |
Jan 10, 2023
Added 20.1%
|
|
Curt Bradshaw
Chief Scientific Officer |
0 | 31,250 | 0 $0 | 2 |
Nov 20, 2020
Reduced 100.0%
|